225 related articles for article (PubMed ID: 32867709)
1. Raised CA19-9 and CEA have prognostic relevance in gallbladder carcinoma.
Sachan A; Saluja SS; Nekarakanti PK; Nimisha ; Mahajan B; Nag HH; Mishra PK
BMC Cancer; 2020 Aug; 20(1):826. PubMed ID: 32867709
[TBL] [Abstract][Full Text] [Related]
2. Elevation of CA19-9 and CEA is associated with a poor prognosis in patients with resectable gallbladder carcinoma.
Wen Z; Si A; Yang J; Yang P; Yang X; Liu H; Yan X; Li W; Zhang B
HPB (Oxford); 2017 Nov; 19(11):951-956. PubMed ID: 28750922
[TBL] [Abstract][Full Text] [Related]
3. The Clinical Role of Preoperative Serum CA19-9 and Carcinoembryonic Antigen (CEA) Levels in Evaluating the Resectability of Advanced Gallbladder Cancer.
Ma W; Li W; Wang J; Wu R; Liu C; Feng F; Jiang X
Med Sci Monit; 2020 Sep; 26():e925017. PubMed ID: 32950997
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.
Sun Z; Zhang N
World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664
[TBL] [Abstract][Full Text] [Related]
5. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
[TBL] [Abstract][Full Text] [Related]
6. Tumor Marker Kinetics as Prognosticators in Patients with Unresectable Gallbladder Adenocarcinoma Undergoing Palliative Chemotherapy.
Lee JW; Kim YT; Lee SH; Son JH; Kang JW; Ryu JK; Jang DK; Paik WH; Lee BS
Gut Liver; 2018 Jan; 12(1):102-110. PubMed ID: 29069888
[TBL] [Abstract][Full Text] [Related]
7. The predictive value of systemic immune inflammation index for postoperative survival of gallbladder carcinoma patients.
Chen H; Huang Z; Sun B; Wang A; Wang Y; Shi H; Zheng T; Li T; Huang M; Fu W
J Surg Oncol; 2021 Jul; 124(1):59-66. PubMed ID: 33765331
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of neutrophil-lymphocyte ratio and carbohydrate antigen 19-9 in patients with gallbladder carcinoma.
Liu F; Hu HJ; Ma WJ; Yang Q; Wang JK; Li FY
Medicine (Baltimore); 2019 Feb; 98(8):e14550. PubMed ID: 30813165
[TBL] [Abstract][Full Text] [Related]
9. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer.
Ychou M; Duffour J; Kramar A; Gourgou S; Grenier J
Dis Markers; 2000; 16(3-4):105-10. PubMed ID: 11381189
[TBL] [Abstract][Full Text] [Related]
11. Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma.
Yang Y; Huang X; Zhou L; Deng T; Ning T; Liu R; Zhang L; Bai M; Zhang H; Li H; Ba Y
BMC Cancer; 2019 May; 19(1):526. PubMed ID: 31151431
[TBL] [Abstract][Full Text] [Related]
12. Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer.
Yin LK; Sun XQ; Mou DZ
Asian Pac J Cancer Prev; 2015; 16(9):3867-70. PubMed ID: 25987051
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of perineural invasion with clinicopathological factors and prognosis for curatively resected gallbladder carcinoma].
Lei JJ; Zhang J; Chen C; Li Q; Su JB; Zhang D; Zhang R; Jin ZC; Geng ZM
Zhonghua Wai Ke Za Zhi; 2022 Jul; 60(7):695-702. PubMed ID: 35775263
[No Abstract] [Full Text] [Related]
14. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy.
Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL
Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876
[TBL] [Abstract][Full Text] [Related]
15. Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer.
Wang YF; Feng FL; Zhao XH; Ye ZX; Zeng HP; Li Z; Jiang XQ; Peng ZH
World J Gastroenterol; 2014 Apr; 20(14):4085-92. PubMed ID: 24744600
[TBL] [Abstract][Full Text] [Related]
16. Combination of tumour markers CEA and CA19-9 improves the prognostic prediction in patients with pancreatic cancer.
Reitz D; Gerger A; Seidel J; Kornprat P; Samonigg H; Stotz M; Szkandera J; Pichler M
J Clin Pathol; 2015 Jun; 68(6):427-33. PubMed ID: 25759406
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic values of anti-helicobacter pylori antibody combined with serum CA724, CA19-9, and CEA for young patients with early gastric cancer.
Gong X; Zhang H
J Clin Lab Anal; 2020 Jul; 34(7):e23268. PubMed ID: 32118318
[TBL] [Abstract][Full Text] [Related]
18. Circulating CEA-dNLR score predicts clinical outcome of metastatic gallbladder cancer patient.
Du JH; Lu J
J Clin Lab Anal; 2019 Feb; 33(2):e22684. PubMed ID: 30461064
[TBL] [Abstract][Full Text] [Related]
19. Nomogram to predict overall survival after gallbladder cancer resection in China.
Bai Y; Liu ZS; Xiong JP; Xu WY; Lin JZ; Long JY; Miao F; Huang HC; Wan XS; Zhao HT
World J Gastroenterol; 2018 Dec; 24(45):5167-5178. PubMed ID: 30568393
[TBL] [Abstract][Full Text] [Related]
20. Clinical value of preoperative CA19-9 levels in evaluating resectability of gallbladder carcinoma.
Liu F; Wang JK; Ma WJ; Yang Q; Hu HJ; Li FY
ANZ J Surg; 2019 Mar; 89(3):E76-E80. PubMed ID: 30306702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]